Autoinflammatory syndromes, characterized by innate immune dysregulation, recurrent fever, and systemic inflammation, are prime examples of IL-1β/IL-1R1 pathway hyperactivity, largely resulting from a failure to control IL-1-mediated signaling. This evidence concerns the gene IL1B and inflammation.